CN Stock MarketDetailed Quotes

002294 Shenzhen Salubris Pharmaceuticals

Watchlist
  • 30.93
  • -0.25-0.80%
Market Closed Nov 15 15:00 CST
34.48BMarket Cap56.44P/E (TTM)

Shenzhen Salubris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shenzhen Salubris Pharmaceuticals Q3 2024 Earnings Date

Currency：CNYOct 22, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
958.43M
--
+24.15%
EPS
0.13
0.15
+0.02
Beat Est.
0.00%
+15.38%
+15.38%
Analyst Rating
Strong Buy

Nov 16, 2024

Shenzhen Salubris Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 29, 20192019/Q31.208B / 1.278B--
Aug 27, 20192019/Q21.168B / 1.229B--
Apr 23, 20192019/Q11.189B / 1.229B--
DatePeriodRevenue/EstimateEarnings Call
Oct 29, 20192019/Q31.208B / 1.278B--
Aug 27, 20192019/Q21.168B / 1.229B--
Apr 23, 20192019/Q11.189B / 1.229B--
--------
--------

Unlock Free Earnings Estimates

Shenzhen Salubris Pharmaceuticals Earnings Reports

  • Xinlitai: Report for the third quarter of 2024

    Oct 21 12:00 ET

  • Xinlitai: 2024 Semi-Annual Report Summary

    Aug 26 12:00 ET

  • Xinlitai: 2024 Semi-Annual Report

    Aug 26 12:00 ET

  • Xinlitai: First Quarter Report 2024

    Apr 22 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 16, 2024

    Strong Buy

    • Strong Buy

      81.25%

    • Buy

      18.75%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data